Publikationer 2016

Use of evidence-based therapy and survival in heart failure in Sweden 2003–2012.

Thorvaldsen T, Benson L, Dahlström U, Edner M, Lund LH

Eur J Heart Fail 2016 May;18(5):503-11


Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure

Isabelle Johansson, Ulf Dahlström, Magnus Edner, Per Näsman, Lars Rydén, Anna Norhammar.

Journal of the American College of Cardiology vol. 68, No. 13, 2016


Prevalence and prognostic impact of kidney disease on heart failure patients.

Löfman I, Szummer K, Hagerman I, Dahlström U, Lund LH, Jernberg T.

Open Heart 2016 Jan 18;3(1)


Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF)

Makubi A, Hage C, Sartipy U, Lwaktare J, Janabi M, Kisenge P, Dahlström U, Rydén L, Makani J, Lund LH.

Int J Cardiol 2016 Oct 1;220:750-8


Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure.

Gijsberts CM, Benson L, Dahlström U, Sim D, Yeo DP, Ong HY Jaufeerally F, Leon GK, Ling LH, Richards AM, de Kleijn DP, Lund LH, Lam CS

Heart. 2016 Sep 15;102(18):1464-71


A comprehensive assessment of the association between anemia, clinical covariates and outcomes in a population-wide heart failure registry

Åsa Jonsson, Ann-Charlotte Hallberg, Magnus Edner, Lars H. Lund, Ulf Dahlström

International Journal of Cardiology 211 (2016) 124–131